248 related articles for article (PubMed ID: 38319453)
41. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.
Mangiapane LR; Nicotra A; Turdo A; Gaggianesi M; Bianca P; Di Franco S; Sardina DS; Veschi V; Signore M; Beyes S; Fagnocchi L; Fiori ME; Bongiorno MR; Lo Iacono M; Pillitteri I; Ganduscio G; Gulotta G; Medema JP; Zippo A; Todaro M; De Maria R; Stassi G
Gut; 2022 Jan; 71(1):119-128. PubMed ID: 33436496
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T
Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919
[TBL] [Abstract][Full Text] [Related]
43. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
44. Possible Role of Cancer Stem Cells in Colorectal Cancer Metastasizing to the Liver.
Jiao ZY; Cao HT; Li YM
Curr Stem Cell Res Ther; 2016; 11(5):440-3. PubMed ID: 26832139
[TBL] [Abstract][Full Text] [Related]
45. Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy.
Feng Y; Gao S; Gao Y; Wang X; Chen Z
Oncotarget; 2016 Dec; 7(49):81402-81409. PubMed ID: 27833077
[TBL] [Abstract][Full Text] [Related]
46. Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies.
Frank MH; Wilson BJ; Gold JS; Frank NY
Gastroenterology; 2021 May; 160(6):1947-1960. PubMed ID: 33617889
[TBL] [Abstract][Full Text] [Related]
47. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
[TBL] [Abstract][Full Text] [Related]
48. The glycosyltransferase ST6Gal-I is enriched in cancer stem-like cells in colorectal carcinoma and contributes to their chemo-resistance.
Cui H; Yang S; Jiang Y; Li C; Zhao Y; Shi Y; Hao Y; Qian F; Tang B; Yu P
Clin Transl Oncol; 2018 Sep; 20(9):1175-1184. PubMed ID: 29423671
[TBL] [Abstract][Full Text] [Related]
49. The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: implications in therapeutic approaches - a mini-review.
Trougakos IP
Gerontology; 2013; 59(6):514-23. PubMed ID: 23689375
[TBL] [Abstract][Full Text] [Related]
50. Heterogeneity of Colon Cancer Stem Cells.
Hirata A; Hatano Y; Niwa M; Hara A; Tomita H
Adv Exp Med Biol; 2019; 1139():115-126. PubMed ID: 31134498
[TBL] [Abstract][Full Text] [Related]
51. Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids.
Ding L; Yang Y; Lu Q; Cao Z; Weygant N
Curr Cancer Drug Targets; 2022; 22(3):195-208. PubMed ID: 35078398
[TBL] [Abstract][Full Text] [Related]
52. Slow-Cycling Cancer Stem Cells Regulate Progression and Chemoresistance in Colon Cancer.
Shiokawa D; Sakai H; Ohata H; Miyazaki T; Kanda Y; Sekine S; Narushima D; Hosokawa M; Kato M; Suzuki Y; Takeyama H; Kambara H; Nakagama H; Okamoto K
Cancer Res; 2020 Oct; 80(20):4451-4464. PubMed ID: 32816913
[TBL] [Abstract][Full Text] [Related]
53. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
Kang XL; He LR; Chen YL; Wang SB
World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
[TBL] [Abstract][Full Text] [Related]
54. Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel.
Hassan MK; Watari H; Christenson L; Bettuzzi S; Sakuragi N
Tumour Biol; 2011 Oct; 32(5):1031-47. PubMed ID: 21761117
[TBL] [Abstract][Full Text] [Related]
55. Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer.
Sogawa C; Eguchi T; Namba Y; Okusha Y; Aoyama E; Ohyama K; Okamoto K
Cells; 2021 Feb; 10(2):. PubMed ID: 33562088
[TBL] [Abstract][Full Text] [Related]
56. Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
Hu YB; Yan C; Mu L; Mi YL; Zhao H; Hu H; Li XL; Tao DD; Wu YQ; Gong JP; Qin JC
Oncogene; 2019 Mar; 38(11):1951-1965. PubMed ID: 30390075
[TBL] [Abstract][Full Text] [Related]
57. Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU.
Samson AAS; Park S; Kim SY; Min DH; Jeon NL; Song JM
J Liposome Res; 2019 Mar; 29(1):44-52. PubMed ID: 29262741
[TBL] [Abstract][Full Text] [Related]
58. Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel.
Hassan MK; Watari H; Han Y; Mitamura T; Hosaka M; Wang L; Tanaka S; Sakuragi N
J Exp Clin Cancer Res; 2011 Dec; 30(1):113. PubMed ID: 22185350
[TBL] [Abstract][Full Text] [Related]
59. Role and molecular mechanism of stem cells in colorectal cancer initiation.
Wang MY; Qiu YH; Cai ML; Zhang CH; Wang XW; Liu H; Chen Y; Zhao WL; Liu JB; Shao RG
J Drug Target; 2020 Jan; 28(1):1-10. PubMed ID: 31244351
[TBL] [Abstract][Full Text] [Related]
60. An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy.
Yang M; Davis TB; Pflieger L; Nebozhyn MV; Loboda A; Wang H; Schell MJ; Thota R; Pledger WJ; Yeatman TJ
BMC Cancer; 2022 Mar; 22(1):256. PubMed ID: 35272617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
